- Home
- PTGX vs EVCM Comparison
PTGX vs EVCM Comparison
Compare PTGX & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | EVCM |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 2.1B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | EVCM |
|---|---|---|
| Price | $86.61 | $11.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 8 |
| Target Price | ★ $90.56 | $11.50 |
| AVG Volume (30 Days) | ★ 932.2K | 338.9K |
| Earning Date | 02-20-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | $209,217,000.00 | ★ $718,038,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $288.98 | $5.60 |
| P/E Ratio | $121.05 | ★ N/A |
| Revenue Growth | N/A | ★ 22.13 |
| 52 Week Low | $33.70 | $7.66 |
| 52 Week High | $96.54 | $14.41 |
Technical Indicators
Market Signals| Indicator | PTGX | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 46.55 | 53.06 |
| Support Level | $84.11 | $11.84 |
| Resistance Level | $89.61 | $12.44 |
| Average True Range (ATR) | 3.03 | 0.76 |
| MACD | -0.73 | -0.06 |
| Stochastic Oscillator | 17.10 | 18.70 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.